Drug Report History #30198

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.

Field Version v10-FR Version v3-FR
Language French French
Date Updated 2018-02-20 (Updated) 2017-11-22
Drug Identification Number 00037974 00037974
Brand name 50% DEXTROSE INJECTION USP 50% DEXTROSE INJECTION USP
Common or Proper name 50% DEXTROSE 50% DEXTROSE
Company Name HOSPIRA HEALTHCARE CORPORATION HOSPIRA HEALTHCARE CORPORATION
Ingredients DEXTROSE DEXTROSE
Strength(s) 500MG 500MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 25x50mL GVL 25x50mL GVL
ATC code B05BA B05BA
ATC description I.V. SOLUTIONS I.V. SOLUTIONS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date (Updated) 2017-12-29
Actual start date 2018-01-19 (Updated)
Estimated end date 2018-03-02 (Updated) 2018-01-22
Actual end date
Shortage status Actual shortage (Updated) Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments